Attacking fibrosis on multiple fronts

Fibrosis is characterized by the excessive or abnormal accumulation of extracellular matrix within tissue, leading to organ dysfunction and disease in a range of conditions. There is a high level of unmet need given that the limited treatments available offer only modest benefits, and new drugs are urgently needed.

Like Comment
Page of
Go to the profile of PharmAkea


PharmAkea is a biopharmaceutical company based in San Diego, CA. The company is developing high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases.

No comments yet.